Selfcare purchases majority stake in Orgenics:
This article was originally published in Clinica
US diagnostics manufacturer Selfcare has acquired 57% of Israeli company Orgenics for $7 million in cash and the conversion of a $1 million debenture. Selfcare announced its intention to purchase Orgenics in its IPO prospectus in June (see Clinica No 713, p 13). It plans to purchase the rest of Orgenics before August 1997.